Press Releases
PMC press releases highlight the significance of the Coalition’s activities in education, advocacy, and evidence development.
A new peer-reviewed study shows that institutions with higher scores on a multi-factorial assessment of personalized medicine integration are more consistently matching cancer patients with genetically guided treatment options.
November 12 , 2024
The Personalized Medicine Coalition (PMC), a 501(c)3-designated nonprofit organization supported by more than 200 businesses, patient advocacy groups, and care delivery institutions, is pleased to announce Amy Nicole Nayar, Pharm.D., M.S., as the Coalition’s next President and CEO.
September 24 , 2024
A new peer-reviewed study shows that institutions with higher scores on a multi-factorial assessment of personalized medicine integration are more consistently matching cancer patients with genetically guided treatment options.
July 8 , 2024
The Personalized Medicine Coalition announces today that its founding president, Edward Abrahams, plans to retire on December 31, 2024, after 20 years of service to the organization.
March 13 , 2024
PMC engaged more than 60 leaders, including 38 from historically underrepresented communities
February 29 , 2024
Pace of personalized rare disease treatment approvals more than doubled, from six in 2022 to 16 in 2023
January 17 , 2024
Reflecting its membership from across the health care spectrum, PMC recently elected five new board members from multiple sectors of the health care ecosystem to help guide the future development of its educational, advocacy, and research programs.
October 18 , 2023
The Personalized Medicine Coalition (PMC) is pleased today to welcome congressman John Moolenaar (R-MI-02) as a new co-chair of the Congressional Personalized Medicine Caucus.
June 14 , 2023
Demonstrating PMC's ability to convene executive leaders from across the health care spectrum, PMC today announced that its board of directors has voted to elect three new board members.
February 23 , 2023
Personalized Medicine at FDA: The Scope & Significance of Progress in 2022 Documents Pharmaceutical Industry Shift Away from One-Size-Fits-All Drugs
November 1 , 2022
Clinical Practice Gaps Likely Inhibiting Impact of Personalized Medicine
April 11 , 2022
Cost-Effectiveness Estimates for Infants Less Than a Year Old and Children Under Age 18 May Inform Provider and Payer Practices
February 22 , 2022
PMC President: Newly Approved Treatments and Diagnostic Tools ‘Leave No Question’ About Emergence of Era of Personalized Medicine, Presenting Both Opportunities and Challenges for Patients and Health Systems
